Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kouro, T.
Right arrow Articles by Takatsu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kouro, T.
Right arrow Articles by Takatsu, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 13, No. 4, 485-493, April 2001
© 2001 Japanese Society for Immunology

Bruton's tyrosine kinase is required for signaling the CD79b-mediated pro-B to pre-B cell transition

Taku Kouro1,4, Kisaburo Nagata2, Satoshi Takaki1, Sazuku Nisitani1,3, Masayuki Hirano1, Matthew I. Wahl3,5, Owen N. Witte3, Hajime Karasuyama2 and Kiyoshi Takatsu1

1 Department of Immunology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai Minato-ku, Tokyo 108-8639, Japan
2 Department of Immunology, Tokyo Metropolitan Institute of Medical Science, 3-18-22 Honkomagome Bunkyo-ku, Tokyo 113-8613, Japan
3 Howard Hughes Medical Institute, and Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, 675 Circle Drive South, Los Angeles, CA 90095, USA

Correspondence to: K. Takatsu

Formation of the pre-BCR complex is a critical check point during B cell development and induces the transition of pro-B to pre-B cells. CD79b (Igß) is a signaling component in the pre-BCR complex, since differentiation to the pre-B phenotype is induced by cross-linking the CD79b expressed on developmentally arrested pro-B cells from recombination-activating gene (RAG)-2-deficient mice. Bruton's tyrosine kinase (BTK) plays important roles in B cell development. However, its molecular mechanisms in early B cell development are not fully understood. To examine whether BTK functions in CD79b-mediated signaling for the pro-B/pre-B transition, we utilized RAG2/BTK double-knockout (DKO) mice. Pro-B cells from RAG2/BTK-DKO mice did not differentiate into pre-B cells following CD79b cross-linking, although tyrosine phosphorylation of cellular proteins including Erk1/2 and phospholipase C-{gamma}2 was induced in the same manner as RAG2-KO mice. BTK is phosphorylated after cross-linking of CD79b on RAG2-deficient pro-B cells. These findings suggest that BTK-dependent pathways downstream of CD79b are critical for the pro-B/pre-B transition and BTK-independent signaling pathways are also activated via the pre-BCR complex.

Keywords: B cell development, Bruton's tyrosine kinase-deficient mice, Igß, pre-BCR, recombination-activating gene-2-deficient mice

4 Present address: Immunobiology and Cancer Program, Oklahoma Medical Research Foundation,825 North East 13th Street, Oklahoma City, OK 73104, USA

5 Deceased

Transmitting editor: T. Watanabe


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
D. A. Martin, L. Lu, M. Cascalho, and G. E. Wu
Maintenance of Surrogate Light Chain Expression Induces Developmental Delay in Early B Cell Compartment
J. Immunol., October 15, 2007; 179(8): 4996 - 5005.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Middendorp, A. J. E. Zijlstra, R. Kersseboom, G. M. Dingjan, H. Jumaa, and R. W. Hendriks
Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity
Blood, January 1, 2005; 105(1): 259 - 265.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Humphries, C. Dangelmaier, K. Sommer, K. Kipp, R. M. Kato, N. Griffith, I. Bakman, C. W. Turk, J. L. Daniel, and D. J. Rawlings
Tec Kinases Mediate Sustained Calcium Influx via Site-specific Tyrosine Phosphorylation of the Phospholipase C{gamma} Src Homology 2-Src Homology 3 Linker
J. Biol. Chem., September 3, 2004; 279(36): 37651 - 37661.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. C. Otero and R. C. Rickert
CD19 Function in Early and Late B Cell Development. II. CD19 Facilitates the Pro-B/Pre-B Transition
J. Immunol., December 1, 2003; 171(11): 5921 - 5930.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Middendorp, G. M. Dingjan, A. Maas, K. Dahlenborg, and R. W. Hendriks
Function of Bruton's Tyrosine Kinase during B Cell Development Is Partially Independent of Its Catalytic Activity
J. Immunol., December 1, 2003; 171(11): 5988 - 5996.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Spaargaren, E. A. Beuling, M. L. Rurup, H. P. Meijer, M. D. Klok, S. Middendorp, R. W. Hendriks, and S. T. Pals
The B Cell Antigen Receptor Controls Integrin Activity through Btk and PLC{gamma}2
J. Exp. Med., November 17, 2003; 198(10): 1539 - 1550.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
R. Kersseboom, S. Middendorp, G. M. Dingjan, K. Dahlenborg, M. Reth, H. Jumaa, and R. W. Hendriks
Bruton's Tyrosine Kinase Cooperates with the B Cell Linker Protein SLP-65 as a Tumor Suppressor in Pre-B Cells
J. Exp. Med., July 7, 2003; 198(1): 91 - 98.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Middendorp, G. M. Dingjan, and R. W. Hendriks
Impaired Precursor B Cell Differentiation in Bruton's Tyrosine Kinase-Deficient Mice
J. Immunol., March 15, 2002; 168(6): 2695 - 2703.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
G. Bannish, E. M. Fuentes-Panana, J. C. Cambier, W. S. Pear, and J. G. Monroe
Ligand-independent Signaling Functions for the B Lymphocyte Antigen Receptor and Their Role in Positive Selection during B Lymphopoiesis
J. Exp. Med., November 26, 2001; 194(11): 1583 - 1596.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.